Furthermore CD8+ T cells engineered to express a ROR1-specific chimeric antigen receptor (CAR) were also able to recognize and lyse primary B-CLL cells, but not normal B cells in vitro [32]. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.